ArticleCancer medicine2023

Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.

Yoshihiko Tasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.